Novo Holdings

Novo Holdings is a Danish holding and investment firm managing the assets of the Novo Nordisk Foundation. Established in 1999, it invests globally in life science companies at all stages of development, with a portfolio also including equities, bonds, real estate, and infrastructure.

Nis Bjørnholt Bak

Principal, Bioindustrial Investments

Jeroen Bakker Ph.D

Partner, Seed Investments

Michael Bauer

Venture Partner

Scott Beardsley

Managing Partner

Raymond Camahort

Principal

Ross Castillo

Associate

Steve Collins

National Account Executive

Emmanuelle Coutanceau Ph.D

Partner, Seed Investments

Kartik Dharmadhikari

Partner, Bioindustrial Investments

Thomas Dyrberg

Partner

Morten Dossing

Partner, Seed Investments

Anna Fan

Partner

Thomas Grotkjær Ph.D

Partner, Bioindustrial Investments

Kenneth Harrison

Partner

Deepa Hingorani

Partner, Planetary Health Investments

Karen Hong

Partner

Johan Hueffer

Senior Partner, Principal Investments

Amit Kakar MD

Managing Partner and Head of Novo Holdings Asia

Navjeewan Khosla

Partner, Novo Holdings Equity Asia

Kasim Kutay

CEO

Abhijeet Lele

Senior Partner and Head of Principal Investments US

Jeffrey Low MD

Principal, Growth Investments

Heather Ludvigsen

Investor

Joe Markson

Associate

Nafise Masoumi

Associate

Peter Moldt

Partner

Daniel O'Connell Ph.D

Partner, Venture Investments

João Ribas Ph.D

Principal, Seed Investments

Naveed Siddiqi

Partner

Eric Snyder

Principal

Matthias Vinther

Senior Associate

Stephen van Helden

Principal, Bioindustrial Investments, Growth Investments

Past deals in Africa

Sylvan

Private Equity Round in 2025
Sylvan Inc. is a biotechnology company specializing in the production and distribution of mushroom spawns, including agaricus, pleurotus, and shiitake strains, as well as casing inoculum. Founded in 1946 and based in Kittanning, Pennsylvania, Sylvan has expanded its operations internationally, with production and sales facilities in multiple countries, including the Netherlands, France, Hungary, and South Africa. The company also offers disease control products and nutritional supplements for the mushroom industry. Additionally, Sylvan engages in solid-state fermentation technology, providing sustainable solutions for various sectors, including food, health, agriculture, and materials. With research and development facilities in the United States and France, Sylvan positions itself as an innovative partner for businesses seeking to enhance their growth through fungal biotechnology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.